|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_0758 | ED149224 | General Research Use | No | Male | White | 79 | 8 - AREDS AMD Severity Scale Step 4 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0940 | ED149377 | General Research Use | No | Male | White | 77 | 8 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_1763 | ED148479 | General Research Use | No | Male | White | 76 | 8 - AREDS AMD Severity Scale Step 6 | 10 - Central GA |
| AR2_1863 | ED148896 | General Research Use | No | Male | White | 77 | 8 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_1976 | ED149376 | General Research Use | No | Male | White | 73 | 8 - AREDS AMD Severity Scale Step 7 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_2287 | ED148200 | General Research Use | No | Female | White | 53 | 8 - AREDS AMD Severity Scale Step 7 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2454 | ED149179 | General Research Use | No | Female | White | 71 | 8 - AREDS AMD Severity Scale Step 8 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_2498 | ED149382 | General Research Use | No | Male | White | 81 | 8 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_2708 | ED149034 | General Research Use | No | Male | White | 80 | 8 - AREDS AMD Severity Scale Step 7 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2827 | ED149032 | General Research Use | No | Female | White | 79 | 8 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_3175 | ED149833 | General Research Use | No | Female | White | 74 | 8 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_3669 | ED148965 | General Research Use | No | Male | White | 66 | 8 - AREDS AMD Severity Scale Step 6 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_4000 | ED149240 | General Research Use | No | Female | White | 81 | 8 - AREDS AMD Severity Scale Step 8 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_4166 | ED149457 | General Research Use | No | Female | White | 72 | 8 - AREDS AMD Severity Scale Step 8 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0452 | ED149352 | General Research Use | No | Female | White | 62 | 8 - AREDS AMD Severity Scale Step 8 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_0543 | ED148544 | General Research Use | No | Female | White | 72 | 8 - AREDS AMD Severity Scale Step 8 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0651 | ED150026 | General Research Use | No | Female | White | 77 | 8 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_0663 | ED148564 | General Research Use | No | Female | White | 84 | 8 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_1576 | ED149621 | Eye Disease Only | No | Female | White | 78 | 8 - AREDS AMD Severity Scale Step 7 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2469 | ED149110 | General Research Use | No | Female | White | 79 | 8 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |